Thomas Navarro FDA Patient Rights Act

Summary

Thomas Navarro FDA Patient Rights Act - Amends the Public Health Service Act to prohibit the Secretary of Health and Human Services from placing a clinical hold on an investigation of a drug on the basis that the Secretary has determined that: (1) there is another drug (including another investigational drug) that is or may be a safe and effective therapy for the disease or condition involved; or (2) there is a comparable or satisfactory alternative therapy available for a patient who is receiving or will receive the drug as a clinical subject in the investigation, subject to exception.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 16 February 2000

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 16 February 2000

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 16 February 2000

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.